| x | x | x |
| a fat soluble substance given to all newborns | |
| synthetic inhibitor of fibrinolysis, inhibits plasminogen activation | |
| P2Y12 is the name of this platelet receptor | |
| Given in an IV bolus, this mutant recombinant t-PA has a longer half life than alteplase and reteplase | |
| serine protease inhibitor, inhibits plasmin mediated fibrinolysis | |
| abciximab, eptifibatide, and tirofiban block this receptor | |
| Thrombolytic drug: a human enzyme that DIRECTLY converts plasminogen to plasmin | |
| TTP and neutropenia are adverse effects of these antiplatelet agents | |
| The final step for the activation of platelet aggregation involves the binding of this receptor | |
| this fibrinolytic inhibitor reduces bleeding from surgery | |
| This protein activates plasminogen into plasmin | |
| this easily deformed cell has receptors for ADP, thrombin, TXA2, and fibrinogen | |
| adverse effects of eaca: | |
| Aka plavix, this prodrug inhibits p2y12 on platelets to prevent thrombosis | |
| Aka christmas disease, hemophilia B is deficient in | |
| This antiplatelet agent is a smaller molecule, similar to eptifibatide | |